Discontinuation report SANDOZ ESOMEPRAZOLE
Report ID | 139203 |
Drug Identification Number | 02460920 |
Brand name | SANDOZ ESOMEPRAZOLE |
Common or Proper name | SANDOZ ESOMEPRAZOLE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 30TAB |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-11-19 |
Remaining supply date | 2020-11-19 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-05-12 | French | Compare |
v1 | 2021-05-12 | English | Compare |
Showing 1 to 2 of 2